Incomplete financial disclosure in a study of cell-free hemoglobin-based blood substitutes and risks of myocardial infarction and death.

Authors	Charles Natanson
Journal	JAMA (JAMA) Vol. 300 Issue 11 Pg. 1300 (Sep 17 2008) ISSN: 1538-3598 [Electronic] United States
PMID	18799441 (Publication Type: Comment, Letter)
Chemical References	Blood Substitutes Hemoglobins
Topics	Blood Substitutes (adverse effects) Hemoglobins (adverse effects) Humans Myocardial Infarction (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!